These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12904236)

  • 1. Resolution of chronic inflammatory demyelinating polyneuropathy-associated central nervous system lesions after treatment with intravenous immunoglobulin.
    Fee DB; Fleming JO
    J Peripher Nerv Syst; 2003 Sep; 8(3):155-8. PubMed ID: 12904236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic inflammatory demyelinating polyradiculoneuropathy associated with multiple sclerosis.
    Sharma KR; Saadia D; Facca AG; Bhatia R; Ayyar DR; Sheremata W
    J Clin Neuromuscul Dis; 2008 Jun; 9(4):385-96. PubMed ID: 18525422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapsing demyelinating disease affecting both the central and peripheral nervous systems.
    Zéphir H; Stojkovic T; Latour P; Lacour A; de Seze J; Outteryck O; Maurage CA; Monpeurt C; Chatelet P; Ovelacq E; Vermersch P
    J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1032-9. PubMed ID: 18208860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid resolution of quadriplegic CIDP by combined plasmapheresis and IVIg.
    Walk D; Li LY; Parry GJ; Day JW
    Neurology; 2004 Jan; 62(1):155-6. PubMed ID: 14718727
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic inflammatory demyelinating polyneuropathy (CIDP): change of serum IgG dimer levels during treatment with intravenous immunoglobulins.
    Ritter C; Bobylev I; Lehmann HC
    J Neuroinflammation; 2015 Aug; 12():148. PubMed ID: 26268846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of anti-neurofascin 155 antibody-positive combined central and peripheral demyelination successfully treated with plasma exchange].
    Shimizu M; Koda T; Nakatsuji Y; Ogata H; Kira JI; Mochizuki H
    Rinsho Shinkeigaku; 2017 Jan; 57(1):41-44. PubMed ID: 28025411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and availability of intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy].
    Iijima M; Koike H; Sobue G
    Nihon Rinsho; 2012 Apr; 70(4):715-21. PubMed ID: 22568158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic inflammatory demyelinating polyradiculoneuropathy associated with central nervous system involvement--as compared to multiple sclerosis].
    Komori T; Ohtake T; Miyazaki Y; Hirose K; Tanabe H
    Rinsho Shinkeigaku; 1990 Sep; 30(9):939-43. PubMed ID: 2265502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting effects of IFNbeta and IVIG in children with central and peripheral demyelination.
    Pirko I; Kuntz NL; Patterson M; Keegan BM; Weinshenker BG; Rodriguez M
    Neurology; 2003 May; 60(10):1697-9. PubMed ID: 12771272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin is effective in patients with diabetes and with chronic inflammatory demyelinating polyneuropathy: long term follow-up.
    Jann S; Bramerio MA; Facchetti D; Sterzi R
    J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):70-3. PubMed ID: 18768571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome.
    Vina ER; Fang AJ; Wallace DJ; Weisman MH
    Semin Arthritis Rheum; 2005 Dec; 35(3):175-84. PubMed ID: 16325658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Chronic Inflammatory Demyelinating Polyneuropathy Ameliorated following High-dose (3 g/kg) Intravenous Immunoglobulin Therapy.
    Seino Y; Nakamura T; Hirohata M; Kawarabayashi T; Okushima T; Shoji M
    Intern Med; 2019 Mar; 58(6):855-859. PubMed ID: 30449785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor-dominant chronic inflammatory demyelinating polyneuropathy.
    Kimura A; Sakurai T; Koumura A; Yamada M; Hayashi Y; Tanaka Y; Hozumi I; Yoshino H; Yuasa T; Inuzuka T
    J Neurol; 2010 Apr; 257(4):621-9. PubMed ID: 20361294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
    Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
    J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
    Brannagan TH
    Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
    Névoret ML; Vinik AI
    J Diabetes Complications; 2015 Mar; 29(2):313-7. PubMed ID: 25466645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A first case of childhood chronic inflammatory demyelinating polyneuropathy associated with alopecia universalis.
    Okubo Y; Miyabayashi T; Sato R; Endo W; Inui T; Togashi N; Haginoya K
    Brain Dev; 2022 Nov; 44(10):748-752. PubMed ID: 35970688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg.
    Caro XJ; Winter EF; Dumas AJ
    Rheumatology (Oxford); 2008 Feb; 47(2):208-11. PubMed ID: 18208823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood chronic inflammatory demyelinating polyneuropathy.
    Nevo Y
    Eur J Paediatr Neurol; 1998; 2(4):169-77. PubMed ID: 10726588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous immunoglobulin infusion: a new therapeutic option in chronic inflammatory demyelinating polyneuropathy.
    Lee DH; Linker RA; Paulus W; Schneider-Gold C; Chan A; Gold R
    Muscle Nerve; 2008 Mar; 37(3):406-9. PubMed ID: 17918749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.